Navigation Links
Watson Acquires Specifar Pharmaceuticals
Date:5/25/2011

PARSIPPANY, N.J. and ATHENS, Greece, May 25, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) and Specifar Pharmaceuticals S.A. today jointly announced that Watson has acquired the privately-held multinational generic pharmaceutical developer, manufacturer and marketer for EUR 400 million ($562 million) in cash and certain contingent consideration. As a result of the acquisition, Watson gains a leading generic product development company that develops and out-licenses products throughout the world.  In addition, this acquisition enhances Watson's commercial presence in key European markets by providing a portfolio of approved products.  The transaction also gives Watson a strong branded-generic commercial presence in the EUR 6 billion Greek pharmaceutical market.  Specifar's pipeline includes a generic tablet version of Nexium® (esomeprazole), which could launch in certain European markets as early as the fourth quarter of 2011. Under the terms of the acquisition agreement, Specifar's former owners could receive additional consideration based on future profits from this product.

Watson anticipates that the transaction will be immediately accretive to 2011 non-GAAP earnings.  

Specifar, with annual revenue of approximately EUR 85 million for 2010, operates two core businesses.  The Company is a third-party product developer, with approximately 400 marketing authorizations licensed to third parties for sale in 36 countries, predominantly in Europe.  Specifar has eight products currently filed in the EU and additional products in development.  The Company's development business, which operates internationally, accounts for more than 70% of total revenues.

The Specifar group is in the top five in the Greek branded-generic market, with a portfolio of more than 30 products, including internally developed and in-lice
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Watsons GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder
2. Delaware Court Rules That Watson Does Not Infringe Patent Related to Generic Version of Concerta(R) and Declares Patent Invalid
3. Watson Confirms Renvela® Patent Challenge
4. Watson Pharmaceuticals Announces New Research Showing RAPAFLO(R) (silodosin) Improves Outcomes for Chronic Prostatitis/Chronic Pelvic Pain Syndrome
5. Duff & Phelps Acquires Lumin Expert Group To Build Global Intellectual Property Practice
6. Safecor Health Acquires Unit-Dose Pharmaceutical Leader RSC
7. Arisyn Therapeutics Inc. Acquires Highly Novel Portfolio of Therapeutic Small Molecules for Infectious Disease and Cancer
8. MediCult Acquires US-Based MidAtlantic Diagnostics to Further Strengthen ART Presence
9. Milestone Scientific Acquires Additional Patent Rights for Painless Injections and Resolves Related Litigations
10. Advanced Instruments Acquires D & F Control Systems Inc.
11. Circassia Acquires North American and Japanese Rights to Dopexamine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Feb. 26, 2015 Protiviti ( www.protiviti.com ), ... of the Governance Portal , designed to increase ... compliance (GRC) tasks across multiple business units and projects. ... help customers better align their controls with the COSO ... ) requirements. In response to client feedback, Protiviti has ...
(Date:2/26/2015)... On behalf of biotech client ... Wilentz, Goldman & Spitzer, P.A. (Wilentz) secured a ... Genewiz Inc. in excess of $10 million. The jury ... secrets, and that it improperly hired one or more ... denying motions for judgment notwithstanding the verdict, a new ...
(Date:2/26/2015)... -- BioEnterprise today announced that Northeast Ohio ... billion in growth funding during the past 13 years.  ... state – including the Ohio Third Frontier - and ... been raised in the past five years. ... BioEnterprise Midwest Healthcare Growth Capital  Report.   ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 Innovation ... are emerging from unexpected parts of the world ... From agriculture to manufacturing to health care, ... and environmental realities and socio-political trends shake the ... the key ingredient for CEOs to survive the ...
Breaking Biology Technology:Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 2More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 4One Million Acts of Innovation Canada Creates Partnership with The Economist Events’ Innovation Forum 2
... to Phlo,Corporation,s ("Phlo"") (OTC: PHLC) press release of December ... York City Account,Base," an affiliate of Phlo (the "Company") ... City has sold and delivered,AQISS(TM) to the following initial ... such roll out. AQISS(TM) is currently available for sale ...
... Denmark, Feb. 11 Santaris Pharma, the,Danish biopharmaceutical ... Keith McCullagh, President and Chief Executive,Officer, will be ... goals for,2008 at the Biotechnology Industry Organisation,s 10th ... Monday February 11th at 12:30 pm,US Eastern Standard ...
... Va., Feb. 11 A report released,today, commissioned by ... of approximately $378 billion over the next 20 years ... The econometric study by economist Dr. Robert J. ... found that "...generic,versions of the top 12 categories of ...
Cached Biology Technology:Phlo Affiliate Reports Progress in New York City Metropolitan Area Roll-Out 2Santaris Pharma to Present at 10th Annual Biotechnology Industry Organisation CEO & Investor Conference - February 11th, 2008 2Study by Leading Economist Identifies Potential for $378 Billion of Savings From Follow On Biologics 2Study by Leading Economist Identifies Potential for $378 Billion of Savings From Follow On Biologics 3Study by Leading Economist Identifies Potential for $378 Billion of Savings From Follow On Biologics 4Study by Leading Economist Identifies Potential for $378 Billion of Savings From Follow On Biologics 5
(Date:2/24/2015)... This report analyzes the worldwide markets for Face and Voice Biometrics ... Biometrics. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , Middle ... Latin America . Annual estimates and forecasts are provided ... is provided for these markets. Market data and analytics are derived ...
(Date:2/19/2015)... DUBLIN , Feb .19, 2015 Research ... announced the addition of the "Military Electro-Optical ... by Sensor Technology, by Platform - Forecast to ... The military electro-optical/infrared systems market is expected ... a CAGR of 7.71%. This report ...
(Date:2/12/2015)... 12, 2015   MedNet Solutions , a ... study management systems, has recently bolstered its ... iMedNet as the eClinical ... and healthcare consultants.  Building on the Program,s existing ... and numerous co-marketing opportunities), MedNet,s new and improved ...
Breaking Biology News(10 mins):World Face and Voice Biometrics Industry 2World Face and Voice Biometrics Industry 3World Face and Voice Biometrics Industry 4World Face and Voice Biometrics Industry 5World Face and Voice Biometrics Industry 6World Face and Voice Biometrics Industry 7World Face and Voice Biometrics Industry 8World Face and Voice Biometrics Industry 9World Face and Voice Biometrics Industry 10World Face and Voice Biometrics Industry 11World Face and Voice Biometrics Industry 12World Face and Voice Biometrics Industry 13World Face and Voice Biometrics Industry 14World Face and Voice Biometrics Industry 15World Face and Voice Biometrics Industry 16Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2
... , This release is available in French ... that brains are sensitive to the quality of child care, ... Lupien and her colleagues from the University of Montreal published ... Sciences . The scientists worked with ten year old children ...
... roads as weed highways, and chemical warfare between alien and native ... in NeoBiota a new open-access, peer-reviewed, rapid ... Pensoft Publishers continuing the former NeoBiota Proceedings ... Khn from the Helmholtz Centre for Environmental Research ...
... Center,s Departments of Orthopaedic Surgery and Radiology found that ... changes in joint cartilage microstructure and provide physicians ... osteoarthritis (OA). By using these techniques during patient exams ... of the disease from eventual joint reconstruction to long-term ...
Cached Biology News:Children of depressed mothers have a different brain 2Open minded and open access: NeoBiota, a new publishing platform for invasion biologists 2Open minded and open access: NeoBiota, a new publishing platform for invasion biologists 3NYU Langone experts find MRI techniques can detect early osteoarthritis 2
Human endothelial progenitor cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Dendritic Cells and EPCs...
Umbilical cord blood neutrophils, For immunohistochemistry (IHC)...
...
Request Info...
Biology Products: